148 related articles for article (PubMed ID: 23712006)
1. The combination of the antiestrogen endoxifen with all-trans-retinoic acid has anti-proliferative and anti-migration effects on melanoma cells without inducing significant toxicity in non-neoplasic cells.
Ribeiro MP; Silva FS; Paixão J; Santos AE; Custódio JB
Eur J Pharmacol; 2013 Sep; 715(1-3):354-62. PubMed ID: 23712006
[TBL] [Abstract][Full Text] [Related]
2. Effects of all-trans-retinoic acid on the permeability transition and bioenergetic functions of rat liver mitochondria in combination with endoxifen.
Ribeiro MP; Santos AE; Santos MS; Custódio JB
Life Sci; 2013 Jul; 93(2-3):96-107. PubMed ID: 23764110
[TBL] [Abstract][Full Text] [Related]
3. The combination of glutamate receptor antagonist MK-801 with tamoxifen and its active metabolites potentiates their antiproliferative activity in mouse melanoma K1735-M2 cells.
Ribeiro MP; Nunes-Correia I; Santos AE; Custódio JB
Exp Cell Res; 2014 Feb; 321(2):288-96. PubMed ID: 24240127
[TBL] [Abstract][Full Text] [Related]
4. The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cells.
Wu X; Hawse JR; Subramaniam M; Goetz MP; Ingle JN; Spelsberg TC
Cancer Res; 2009 Mar; 69(5):1722-7. PubMed ID: 19244106
[TBL] [Abstract][Full Text] [Related]
5. All trans-retinoic acid acts synergistically with hydroxytamoxifen and transforming-growth factor beta to stimulate apoptosis in MCF-7 breast cancer cells.
Danforth DN
J Endocrinol; 2004 Nov; 183(2):395-404. PubMed ID: 15531727
[TBL] [Abstract][Full Text] [Related]
6. The antiestrogen 4-hydroxytamoxifen protects against isotretinoin-induced permeability transition and bioenergetic dysfunction of liver mitochondria: comparison with tamoxifen.
Silva FS; Ribeiro MP; Santos MS; Rocha-Pereira P; Santos-Silva A; Custódio JB
J Bioenerg Biomembr; 2013 Aug; 45(4):383-96. PubMed ID: 23779226
[TBL] [Abstract][Full Text] [Related]
7. Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells?
Czeczuga-Semeniuk E; Anchim T; Dziecioł J; Dabrowska M; Wołczyński S
Acta Biochim Pol; 2004; 51(3):733-45. PubMed ID: 15448735
[TBL] [Abstract][Full Text] [Related]
8. Orally administered endoxifen inhibits tumor growth in melanoma-bearing mice.
Chen P; Sheikh S; Ahmad A; Ali SM; Ahmad MU; Ahmad I
Cell Mol Biol Lett; 2018; 23():3. PubMed ID: 29308069
[TBL] [Abstract][Full Text] [Related]
9. Orally administered endoxifen is a new therapeutic agent for breast cancer.
Ahmad A; Ali SM; Ahmad MU; Sheikh S; Ahmad I
Breast Cancer Res Treat; 2010 Jul; 122(2):579-84. PubMed ID: 20052538
[TBL] [Abstract][Full Text] [Related]
10. Effect of tamoxifen and retinoic acid on bradykinin induced proliferation in MCF-7 cells.
Searovic P; Alonso M; Oses C; Pereira-Flores K; Velarde V; Saez CG
J Cell Biochem; 2009 Feb; 106(3):473-81. PubMed ID: 19115248
[TBL] [Abstract][Full Text] [Related]
11. 13-cis retinoic acid and all-trans retinoic acid in the regulation of the proliferation and survival of human breast cancer cell line MCF-7.
Czeczuga-Semeniuk E; Wolczyński S; Dziecioł J; Dabrowska M; Anchim T; Tomaszewska I
Cell Mol Biol Lett; 2001; 6(4):925-39. PubMed ID: 11753438
[TBL] [Abstract][Full Text] [Related]
12. Influence of the level of gamma-glutamyltranspeptidase activity on the response of poorly and moderately differentiated rhabdomyosarcoma cell lines to all-trans-retinoic acid.
Palomares T; Castro B; del Olmo M; Iglesias A; Bilbao P; Alonso-Varona A
Anticancer Drugs; 2006 Nov; 17(10):1127-39. PubMed ID: 17075312
[TBL] [Abstract][Full Text] [Related]
13. Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells.
Piccolella M; Crippa V; Messi E; Tetel MJ; Poletti A
Pharmacol Res; 2014 Jan; 79():13-20. PubMed ID: 24184124
[TBL] [Abstract][Full Text] [Related]
14. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
Cernaianu G; Brandmaier P; Scholz G; Ackermann OP; Alt R; Rothe K; Cross M; Witzigmann H; Tröbs RB
J Pediatr Surg; 2008 Jul; 43(7):1284-94. PubMed ID: 18639684
[TBL] [Abstract][Full Text] [Related]
15. Determination of clinically therapeutic endoxifen concentrations based on efficacy from human MCF7 breast cancer xenografts.
Gong IY; Teft WA; Ly J; Chen YH; Alicke B; Kim RB; Choo EF
Breast Cancer Res Treat; 2013 May; 139(1):61-9. PubMed ID: 23605084
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells.
Hodges-Gallagher L; Valentine CD; Bader SE; Kushner PJ
Breast Cancer Res Treat; 2007 Nov; 105(3):297-309. PubMed ID: 17186358
[TBL] [Abstract][Full Text] [Related]
17. All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells.
Li RJ; Ying X; Zhang Y; Ju RJ; Wang XX; Yao HJ; Men Y; Tian W; Yu Y; Zhang L; Huang RJ; Lu WL
J Control Release; 2011 Feb; 149(3):281-91. PubMed ID: 20971141
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism and cytotoxicity of allicin and all-trans retinoic acid against CD44
Jobani BM; Najafzadeh N; Mazani M; Arzanlou M; Vardin MM
Phytomedicine; 2018 Sep; 48():161-169. PubMed ID: 30195874
[TBL] [Abstract][Full Text] [Related]
19. Boronic prodrug of endoxifen as an effective hormone therapy for breast cancer.
Zhang C; Zhong Q; Zhang Q; Zheng S; Miele L; Wang G
Breast Cancer Res Treat; 2015 Jul; 152(2):283-91. PubMed ID: 26071758
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effects of retinoic acid and tamoxifen on human breast cancer cells: proteomic characterization.
Wang Y; He QY; Chen H; Chiu JF
Exp Cell Res; 2007 Jan; 313(2):357-68. PubMed ID: 17098229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
